Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism

P Bohanec Grabar, D Logar, B Lestan… - European journal of …, 2008 - Springer
Objective Methotrexate (MTX) is a disease-modifying antirheumatic drug used in the
treatment of rheumatoid arthritis (RA). Genetic polymorphisms of reduced folate carrier …

Genetic determinants of methotrexate toxicity in tunisian patients with rheumatoid arthritis: a study of polymorphisms involved in the MTX metabolic pathway

S Chaabane, S Marzouk, R Akrout… - European journal of …, 2016 - Springer
Abstract Background and Objective Methotrexate (MTX) is a disease-modifying anti-
rheumatic drug used in the treatment of rheumatoid arthritis (RA). It is the first line drug in the …

Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.

P Ranganathan, R Culverhouse, S Marsh… - The Journal of …, 2008 - jrheum.org
OBJECTIVE: Research has examined the association of folate-dependent gene
polymorphisms with methotrexate (MTX) toxicity in racially homogenous patients with …

Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity

MC Fisher, BN Cronstein - The Journal of rheumatology, 2009 - jrheum.org
Objective. Methotrexate (MTX) is an effective therapy for rheumatoid arthritis (RA) but it is
also associated with toxicity. Pharmacogenetics is the systematic evaluation of the role of …

Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis

GG Song, SC Bae, YH Lee - Clinical rheumatology, 2014 - Springer
The aim of this study was to explore whether the C677T and A1298C polymorphisms of
methylenetetrahydrofolate reductase (MTHFR) play a role in methotrexate (MTX) toxicity in …

[PDF][PDF] Association of dihydrofolate reductase (DHFR)-317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis

V Milic, B Jekic, L Lukovic, V Bunjevacki… - Clinical and …, 2012 - clinexprheumatol.org
Objectives Identifying genetic predictors of methotrexate (MTX) treatment response in
patients with rheumatoid arthritis (RA) may have great importance for optimising drug doses …

Association Between MTHFR C677T Polymorphism and Methotrexate Treatment Outcome in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis

W Shao, Y Yuan, Y Li - Genetic Testing and Molecular Biomarkers, 2017 - liebertpub.com
Purpose: Methotrexate (MTX) is one of the most widely used disease-modifying
antirheumatic drugs for the treatment of rheumatoid arthritis (RA). However, its efficacy in RA …

Are Thymidylate synthase and Methylene tetrahydrofolate reductase genes linked with methotrexate response (efficacy, toxicity) in Indian (Asian) rheumatoid arthritis …

Y Ghodke, A Chopra, K Joshi, B Patwardhan - Clinical rheumatology, 2008 - Springer
Methotrexate (MTX) is among the best-tolerated disease-modifying antirheumatic drugs for
the treatment of rheumatoid arthritis (RA); major drawbacks of MTX therapy are the large …

677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis

M Kurzawski, A Pawlik, K Safranow, M Herczynska… - 2007 - Future Medicine
Introduction: Methotrexate (MTX), widely used in the treatment of rheumatoid arthritis (RA),
inhibits dihydrofolate reductase and folate-dependent enzymes. Methylenetetrahydrofolate …

Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity: a meta-analysis

KP Spyridopoulou, NL Dimou… - Pharmacogenetics …, 2012 - journals.lww.com
Objective A systematic review and a meta-analysis were conducted, to investigate the
possible association of methylene tetrahydrofolate reductase (MTHFR) gene polymorphisms …